BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30409089)

  • 1. Synergistic effect of phosphodiesterase 4 inhibitor and serum on migration of endotoxin-stimulated macrophages.
    Yang JX; Hsiung TC; Weng FC; Ding SL; Wu CP; Conti M; Chuang TH; Catherine Jin SL
    Innate Immun; 2018 Nov; 24(8):501-512. PubMed ID: 30409089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages.
    Yang JX; Hsieh KC; Chen YL; Lee CK; Conti M; Chuang TH; Wu CP; Jin SC
    Sci Rep; 2017 Apr; 7():46165. PubMed ID: 28383060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck.
    Ribeiro ASF; Fernandes VS; Martínez-Sáenz A; Martínez P; Barahona MV; Orensanz LM; Blaha I; Serrano-Margüello D; Bustamante S; Carballido J; García-Sacristán A; Prieto D; Hernández M
    J Sex Med; 2014 Apr; 11(4):930-941. PubMed ID: 24754330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.
    Kenk M; Thomas A; Lortie M; Dekemp R; Beanlands RS; Dasilva JN
    Curr Radiopharm; 2011 Jan; 4(1):44-58. PubMed ID: 22191614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1.
    Korhonen R; Hömmö T; Keränen T; Laavola M; Hämäläinen M; Vuolteenaho K; Lehtimäki L; Kankaanranta H; Moilanen E
    Br J Pharmacol; 2013 Aug; 169(7):1525-36. PubMed ID: 23849041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.
    Avila DV; Barker DF; Zhang J; McClain CJ; Barve S; Gobejishvili L
    J Pathol; 2016 Sep; 240(1):96-107. PubMed ID: 27287961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors.
    Arcaro CA; Assis RP; Oliveira JO; Zanon NM; Paula-Gomes S; Navegantes LCC; Kettelhut IC; Brunetti IL; Baviera AM
    Life Sci; 2021 Aug; 278():119563. PubMed ID: 33930364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.
    Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A
    J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phosphodiesterase-4 decreases ethanol intake in mice.
    Hu W; Lu T; Chen A; Huang Y; Hansen R; Chandler LJ; Zhang HT
    Psychopharmacology (Berl); 2011 Nov; 218(2):331-9. PubMed ID: 21509503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation.
    Avila DV; Myers SA; Zhang J; Kharebava G; McClain CJ; Kim HY; Whittemore SR; Gobejishvili L; Barve S
    Neuropharmacology; 2017 Oct; 125():376-385. PubMed ID: 28807677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
    Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J
    PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):425-36. PubMed ID: 8809029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in Mice.
    Wang ZZ; Yang WX; Zhang Y; Zhao N; Zhang YZ; Liu YQ; Xu Y; Wilson SP; O'Donnell JM; Zhang HT; Li YF
    Sci Rep; 2015 Jul; 5():11332. PubMed ID: 26161529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats.
    Zhang HT; Huang Y; Mishler K; Roerig SC; O'Donnell JM
    Psychopharmacology (Berl); 2005 Oct; 182(1):104-15. PubMed ID: 16010541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase-4 inhibition improves corticosteroid insensitivity in pulmonary endothelial cells under oxidative stress.
    Ortiz JL; Milara J; Lluch J; De Diego A; Sanz C; Cortijo J
    Allergy; 2013 Jan; 68(1):64-73. PubMed ID: 23121078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase-4 inhibition reduces ECLS-induced vascular permeability and improves microcirculation in a rodent model of extracorporeal resuscitation.
    Wollborn J; Siemering S; Steiger C; Buerkle H; Goebel U; Schick MA
    Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H751-H761. PubMed ID: 30681364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues.
    Yougbare I; Morin C; Senouvo FY; Sirois C; Albadine R; Lugnier C; Rousseau E
    Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L441-50. PubMed ID: 21784969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for reprogramming of monocytes into reparative alveolar macrophages in vivo by targeting PDE4b.
    Rochford I; Joshi JC; Rayees S; Anwar M; Akhter MZ; Yalagala L; Banerjee S; Mehta D
    Am J Physiol Lung Cell Mol Physiol; 2021 Oct; 321(4):L686-L702. PubMed ID: 34318714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition.
    Abusnina A; Keravis T; Zhou Q; Justiniano H; Lobstein A; Lugnier C
    Thromb Haemost; 2015 Feb; 113(2):319-28. PubMed ID: 25230992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.
    Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C
    Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.